المؤلفون: Marcello Tiseo, Godefridus J. Peters, Paul Germonpré, Christian Rolfo, Nele Van Der Steen, Christophe Hermans, Giulia Mazzaschi, Elisa Giovannetti, Karen Zwaenepoel, Daan P. Geerke, Patrick Pauwels, Paul Van Schil, Ken Op de Beeck, Filip Lardon, Rosa A. Luirink

المساهمون: Medical oncology laboratory, AGEM - Re-generation and cancer of the digestive system, CCA - Imaging and biomarkers, AIMMS, Molecular and Computational Toxicology

المصدر: Molecules
Volume 24
Issue 24
Molecules: a journal of synthetic chemistry and natural product chemistry
Molecules, 24(24). Multidisciplinary Digital Publishing Institute
van der Steen, N, Zwaenepoel, K, Mazzaschi, G, A Luirink, R, P Geerke, D, op de Beeck, K, Hermans, C, Tiseo, M, van Schil, P, Lardon, F, Germonpré, P, Rolfo, C, Giovannetti, E, J Peters, G & Pauwels, P 2019, ' The Role of c-Met as a Biomarker and Player in Innate and Acquired Resistance in Non-Small-Cell Lung Cancer: Two New Mutations Warrant Further Studies ', Molecules, vol. 24, no. 24 . https://doi.org/10.3390/molecules24244443Test
Molecules, 24(24):4443. Multidisciplinary Digital Publishing Institute (MDPI)
Van Der Steen, N, Zwaenepoel, K, Mazzaschi, G, Luirink, R A, Geerke, D P, De Beeck, K O, Hermans, C, Tiseo, M, Van Schil, P, Lardon, F, Germonpré, P, Rolfo, C, Giovannetti, E, Peters, G J & Pauwels, P 2019, ' The role of c-met as a biomarker and player in innate and acquired resistance in non-small-cell lung cancer : Two new mutations warrant further studies ', Molecules, vol. 24, no. 24, 4443 . https://doi.org/10.3390/molecules24244443Test

مصطلحات موضوعية: Male, Lung Neoplasms, Mutant, Pharmaceutical Science, NSCLC, Analytical Chemistry, chemistry.chemical_compound, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Drug Discovery, Epidermal growth factor receptor, Neoplasm Metastasis, Receptor, 0303 health sciences, biology, Middle Aged, Proto-Oncogene Proteins c-met, 3. Good health, ErbB Receptors, Gene Expression Regulation, Neoplastic, Chemistry, Chemistry (miscellaneous), 030220 oncology & carcinogenesis, Molecular Medicine, Biomarker (medicine), Female, Antibody, Adult, C-Met, EGFR, Article, Deep sequencing, 03 medical and health sciences, SDG 3 - Good Health and Well-being, Biomarkers, Tumor, medicine, Humans, Physical and Theoretical Chemistry, Lung cancer, Biology, Aged, 030304 developmental biology, business.industry, Organic Chemistry, Gene Amplification, medicine.disease, chemistry, Drug Resistance, Neoplasm, Mutation, biology.protein, Cancer research, Tumor Suppressor Protein p53, business, Biomarkers

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d41c017861e5a2eba24b3519c13c0ba8Test
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85076355617&origin=inwardTest

المؤلفون: Godefridus J. Peters, Isabella Vittimberga, Editta Baldini, Myriam Chartoire, Luca Boni, Marcello Tiseo, Matteo Brighenti, Fausto Barbieri, Andrea Camerini, Elisa Giovannetti, Francesca Mazzoni, Carmelo Tibaldi, Annalisa Gilli, Richard J. Honeywell

المساهمون: CCA - Imaging and biomarkers, Medical oncology laboratory, AGEM - Re-generation and cancer of the digestive system

المصدر: British journal of cancer, 119(11), 1326-1331. Nature Publishing Group
British Journal of Cancer, 119(11), 1326-1331. Nature Publishing Group
Tibaldi, C, Camerini, A, Tiseo, M, Mazzoni, F, Barbieri, F, Vittimberga, I, Brighenti, M, Boni, L, Baldini, E, Gilli, A, Honeywell, R, Chartoire, M, Peters, G J, Giovannetti, E & Italian Oncological Group of Clinical Research (GOIRC) 2018, ' Cytidine deaminase enzymatic activity is a prognostic biomarker in gemcitabine/platinum-treated advanced non-small-cell lung cancer : a prospective validation study ', British Journal of Cancer, vol. 119, no. 11, pp. 1326-1331 . https://doi.org/10.1038/s41416-018-0307-3Test
British Journal of Cancer

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Predictive markers, Deoxycytidine, Article, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, Medical research, Internal medicine, Carcinoma, Non-Small-Cell Lung, Cytidine Deaminase, Antineoplastic Combined Chemotherapy Protocols, medicine, Carcinoma, Biomarkers, Tumor, Humans, Prospective Studies, Prospective cohort study, Lung cancer, Survival rate, Aged, Retrospective Studies, Aged, 80 and over, business.industry, Retrospective cohort study, Cytidine deaminase, Middle Aged, medicine.disease, Prognosis, Gemcitabine, 030104 developmental biology, 030220 oncology & carcinogenesis, Biomarker (medicine), Female, Cisplatin, business, Non-small-cell lung cancer, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70a41cf0b0a4002de132af4198423642Test
https://pure.amc.nl/en/publications/cytidine-deaminase-enzymatic-activity-is-a-prognostic-biomarker-in-gemcitabineplatinumtreated-advanced-nonsmallcell-lung-cancer-a-prospective-validation-studyTest(297ba0b2-d07b-4b73-bc30-89fce3b095d5).html

المؤلفون: Elisa Giovannetti, Laura L. Meijer, Jisce R. Puik, Geert Kazemier, Godefridus J. Peters

المساهمون: Surgery, Medical oncology laboratory, CCA - Target Discovery & Preclinial Therapy Development

المصدر: Meijer, L L, Puik, J R, Peters, G J, Kazemier, G & Giovannetti, E 2016, ' hENT-1 Expression and Localization Predict Outcome After Adjuvant Gemcitabine in Resected Cholangiocarcinoma Patients ', The Oncologist, vol. 21, no. 12, pp. e4 . https://doi.org/10.1634/theoncologist.2016-0262Test
The Oncologist
The Oncologist, 21(12). AlphaMed Press

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, medicine.medical_specialty, Antimetabolites, Antineoplastic, medicine.medical_treatment, Treatment outcome, Equilibrative nucleoside transporter 1, Deoxycytidine, Disease-Free Survival, Cholangiocarcinoma, Equilibrative Nucleoside Transporter 1, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Humans, In patient, Letters to the Editor, Aged, Chemotherapy, biology, business.industry, Middle Aged, Gemcitabine, 030104 developmental biology, Bile Duct Neoplasms, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, biology.protein, Biomarker (medicine), Female, business, Adjuvant, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2356f1bce196ea80a75555ea4263dae6Test
https://doi.org/10.1634/theoncologist.2016-0262Test

المؤلفون: Anna E. Huis In ‘t Veld, Michel M van den Heuvel, Pieter Wesseling, Niki Karachaliou, Nik Sol, Aniko V. Fejes, Adrianus J. de Langen, Michal Heger, Pepijn Schellen, Laura L. Meijer, Jilian D. Schoonhoven, Hanne Meijers-Heijboer, Sjors G J G In 't Veld, Bakhos A. Tannous, Irsan E. Kooi, Jose Gomez-Arroyo, Jillian Bracht, Rafael Rosell, Anna Larissa N. Niemeijer, Joep Killestein, Mirte Muller, Michelle Esenkbrink, Egbert F. Smit, Imo E. Hoefer, Jihane Tannous, Elizabeth Lee-Lewandrowski, Geert Kazemier, Heleen Verschueren, Francesca Favaro, Sander Idema, Bauke Ylstra, François Rustenburg, Rolf T. Urbanus, W. Peter Vandertop, Laurine E. Wedekind, Christine Mannhalter, Harm Jan Bogaard, Cyra E. Leurs, Adrienne Vancura, Lee Ann Tjon Kon Fat, Edward Post, Leon J Wils, Myron G. Best, Saskia C.A. de Jager, R. Jonas A. Nilsson, Jaap C. Reijneveld, Gerard Pasterkamp, Tessa Y S Le Large, Kent B. Lewandrowski, Elisa Giovannetti, Daan van den Broek, David P. Noske, Thomas Wurdinger

المساهمون: Neurosurgery, Neurology, Pulmonary medicine, ACS - Pulmonary hypertension & thrombosis, CCA - Imaging and biomarkers, Medical oncology laboratory, Surgery, AGEM - Re-generation and cancer of the digestive system, Human genetics, Amsterdam Neuroscience - Neuroinfection & -inflammation, Pathology, Amsterdam Neuroscience - Systems & Network Neuroscience, Amsterdam Neuroscience - Brain Imaging, Amsterdam Reproduction & Development (AR&D), Graduate School, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism

المصدر: Cancer Cell, 32(2), 238-252.e9. Cell Press
Cancer Cell
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Cancer Cell, 32, 238-252.e9
Best, M G, Sol, N, In ‘t Veld, S G J G, Vancura, A, Muller, M, Niemeijer, A L N, Fejes, A V, Tjon Kon Fat, L A, Huis In ‘t Veld, A E, Leurs, C, Le Large, T Y, Meijer, L L, Kooi, I E, Rustenburg, F, Schellen, P, Verschueren, H, Post, E, Wedekind, L E, Bracht, J, Esenkbrink, M, Wils, L, Favaro, F, Schoonhoven, J D, Tannous, J, Meijers-Heijboer, H, Kazemier, G, Giovannetti, E, Reijneveld, J C, Idema, S, Killestein, J, Heger, M, de Jager, S C, Urbanus, R T, Hoefer, I E, Pasterkamp, G, Mannhalter, C, Gomez-Arroyo, J, Bogaard, H J, Noske, D P, Vandertop, W P, van den Broek, D, Ylstra, B, Nilsson, R J A, Wesseling, P, Karachaliou, N, Rosell, R, Lee-Lewandrowski, E, Lewandrowski, K B, Tannous, B A, de Langen, A J, Smit, E F, van den Heuvel, M M & Wurdinger, T 2017, ' Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets ', Cancer Cell, vol. 32, no. 2, pp. 238-252.e9 . https://doi.org/10.1016/j.ccell.2017.07.004Test
Cancer Cell, 32(2), 238. Cell Press
Cancer Cell, 32, 2, pp. 238-252.e9
Cancer cell, 32(2), 238-252.e9. Cell Press

مصطلحات موضوعية: Male, 0301 basic medicine, Cancer Research, Lung Neoplasms, Support Vector Machine, blood platelets, Blood Platelets/physiology, NSCLC, Carcinoma, Non-Small-Cell Lung/blood, Swarm intelligence, Cohort Studies, liquid biopsies, Carcinoma, Non-Small-Cell Lung, Diagnosis, 80 and over, Computer-Assisted/methods, Platelet, Diagnosis, Computer-Assisted, particle-swarm optimization, Aged, 80 and over, Tumor, cancer diagnostics, Non-Small-Cell Lung/blood, swarm intelligence, High-Throughput Nucleotide Sequencing, Middle Aged, 3. Good health, Diagnosis, Computer-Assisted/methods, Oncology, self-learning algorithms, Biomarker (medicine), Female, Non small cell, Algorithms, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9], Blood Platelets, Adult, Inflammation/blood, Rare cancers Radboud Institute for Molecular Life Sciences [Radboudumc 9], Article, Lung Neoplasms/blood, splicing, 03 medical and health sciences, Artificial Intelligence, Biomarkers, Tumor, medicine, Humans, Lung cancer, Aged, Inflammation, Cancer och onkologi, business.industry, Gene Expression Profiling, Carcinoma, Cancer, Cell Biology, medicine.disease, tumor-educated platelets, 030104 developmental biology, Cancer and Oncology, Immunology, Cancer research, RNA, business, Biomarkers

وصف الملف: application/pdf; image/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14b4b869f8ee10ef55699cd8a7901a32Test
https://doi.org/10.1016/j.ccell.2017.07.004Test

المؤلفون: Marco Del Chiaro, Jin Hyeok Hwang, Elisa Giovannetti, Sun-Whe Kim, Gyeong Hoon Kang, Joo Kyung Park, Godefridus J. Peters, Niccola Funel, Giuseppe Giaccone, Yong-Tae Kim, Leticia G. Leon, Johannes Voortman, Min A Kim, Seth M. Steinberg

المساهمون: Medical oncology, Medical oncology laboratory, CCA - Innovative therapy

المصدر: PLoS ONE, 5(5):e10630. Public Library of Science
PLoS ONE, Vol 5, Iss 5, p e10630 (2010)
Hwang, J H, Voortman, J, Giovannetti, E, Steinberg, S M, Leon, L G, Kim, Y T, Funel, N, Park, J K, Kim, M A, Kang, G H, Kim, S W, Del Chiaro, M, Peters, G J & Giaccone, G 2010, ' Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer ', PLoS ONE, vol. 5, no. 5, e10630, pp. e10630 . https://doi.org/10.1371/journal.pone.0010630Test
PLoS ONE

مصطلحات موضوعية: Male, Oncology, Pathology, medicine.medical_treatment, Gastroenterology and Hepatology/Pancreas, lcsh:Medicine, Cohort Studies, Recurrence, Medicine, lcsh:Science, Oligonucleotide Array Sequence Analysis, Multidisciplinary, Hazard ratio, Middle Aged, Gene Expression Regulation, Neoplastic, Treatment Outcome, Italy, Chemotherapy, Adjuvant, Fluorouracil, Biomarker (medicine), Female, Adjuvant, Research Article, Carcinoma, Pancreatic Ductal, medicine.drug, medicine.medical_specialty, Gastroenterology and Hepatology/Gastrointestinal Cancers, Oncology/Gastrointestinal Cancers, Disease-Free Survival, Pancreatic cancer, Internal medicine, Biomarkers, Tumor, Adjuvant therapy, Carcinoma, Humans, Molecular Biology, Genetics and Genomics/Cancer Genetics, Aged, Cell Proliferation, Proportional Hazards Models, Korea, business.industry, Proportional hazards model, lcsh:R, Reproducibility of Results, medicine.disease, Pancreatic Neoplasms, MicroRNAs, Drug Resistance, Neoplasm, Multivariate Analysis, lcsh:Q, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82084ac8872d14c0371f6226ddffd380Test
https://research.vumc.nl/en/publications/395c4790-f76e-41bb-9005-55a897b80fc6Test

المؤلفون: Armando Santoro, Alfredo Falcone, Giuseppe Giaccone, Godefridus J. Peters, Jacobus A. Burgers, Elisa Giovannetti, Romano Danesi, Armida D'Incecco, Paolo Andrea Zucali, Carmelo Tibaldi, Filippo Cortesi, Egbert F. Smit

المساهمون: Medical oncology laboratory, Pulmonary medicine, CCA - Innovative therapy

المصدر: Web of Science
Molecular Cancer Therapeutics, 9(3), 581-593. American Association for Cancer Research Inc.
Giovannetti, E, Zucali, P A, Peters, G J, Cortesi, F, D'Incecco, A, Smit, E F, Falcone, A, Burgers, J A, Santoro, A, Danesi, R, Giaccone, G & Tibaldi, C 2010, ' Association of Polymorphisms in AKT1 and EGFR with Clinical Outcome and Toxicity in Non-Small Cell Lung Cancer Patients Treated with Gefitinib ', Molecular Cancer Therapeutics, vol. 9, no. 3, pp. 581-593 . https://doi.org/10.1158/1535-7163.MCT-09-0665Test
Università di Pisa-IRIS
Publons

مصطلحات موضوعية: Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Drug-Related Side Effects and Adverse Reactions, Population, Antineoplastic Agents, Pharmacology, Polymorphism, Single Nucleotide, Biomarkers, Pharmacological, Gefitinib, Internal medicine, Carcinoma, Non-Small-Cell Lung, Genotype, medicine, Humans, Epidermal growth factor receptor, Lung cancer, education, neoplasms, Survival analysis, Aged, Retrospective Studies, Aged, 80 and over, education.field_of_study, biology, business.industry, Middle Aged, medicine.disease, Prognosis, Survival Analysis, respiratory tract diseases, ErbB Receptors, Treatment Outcome, Drug Resistance, Neoplasm, biology.protein, Quinazolines, Biomarker (medicine), Female, business, Proto-Oncogene Proteins c-akt, Pharmacogenetics, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9fc4b7b10a929beaed8b02a975360daTest
https://publons.com/wos-op/publon/27272248Test/